Free Trial

Synopsys (SNPS) Stock Forecast & Price Target

Synopsys logo
$520.58 +7.87 (+1.53%)
As of 11:01 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Synopsys - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
1
Buy
10

Based on 11 Wall Street analysts who have issued ratings for Synopsys in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 1 has given a hold rating, and 10 have given a buy rating for SNPS.

Consensus Price Target

$641.82
23.29% Upside
According to the 11 analysts' twelve-month price targets for Synopsys, the average price target is $641.82. The highest price target for SNPS is $690.00, while the lowest price target for SNPS is $540.00. The average price target represents a forecasted upside of 23.29% from the current price of $520.58.
Get the Latest News and Ratings for SNPS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Synopsys and its competitors.

Sign Up

SNPS Analyst Ratings Over Time

TypeCurrent Forecast
1/31/24 to 1/30/25
1 Month Ago
1/1/24 to 12/31/24
3 Months Ago
11/2/23 to 11/1/24
1 Year Ago
1/31/23 to 1/31/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
10 Buy rating(s)
9 Buy rating(s)
11 Buy rating(s)
9 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$641.82$649.00$643.00$576.60
Forecasted Upside23.29% Upside33.72% Upside24.04% Upside8.11% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Buy

SNPS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SNPS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Synopsys Stock vs. The Competition

TypeSynopsysComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.91
2.68
2.52
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside25.18% Upside58.63% Upside12.29% Upside
News Sentiment Rating
Positive News

See Recent SNPS News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/13/2025Wells Fargo & Company
3 of 5 stars
J. Quatrochi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$570.00 ➝ $540.00+9.93%
1/13/2025Redburn Atlantic
5 of 5 stars
L. Brown
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$600.00+21.82%
12/6/2024Piper Sandler
2 of 5 stars
 Lower TargetOverweight ➝ Overweight$670.00 ➝ $655.00+27.11%
12/5/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$644.00 ➝ $630.00+7.14%
12/5/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$640.00 ➝ $640.00+8.84%
12/4/2024Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$635.00 ➝ $635.00+11.37%
11/11/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Mobley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$675.00+21.35%
10/22/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Panigrahi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$650.00+28.56%
10/15/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Naing
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$660.00+21.00%
8/22/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$655.00 ➝ $685.00+21.10%
6/27/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$675.00 ➝ $690.00+15.28%
11/27/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$550.00+0.92%
11/10/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOverweight$600.00+17.88%
10/10/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$510.00 ➝ $600.00+24.02%
9/29/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$551.00+19.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:01 AM ET.


Should I Buy Synopsys Stock? SNPS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, January 23, 2025. Please send any questions or comments about these Synopsys pros and cons to contact@marketbeat.com.

Synopsys
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Synopsys, Inc.:

  • Synopsys, Inc. has received multiple "buy" ratings from analysts, indicating strong confidence in the company's future performance. Eleven analysts have assigned a buy rating, suggesting a positive outlook.
  • The current stock price is $526.70, which is near its fifty-two week high of $629.38, indicating strong market interest and potential for growth.
  • Analysts have set a consensus price target of $641.82, which is higher than the current stock price, suggesting potential upside for investors.
  • Synopsys, Inc. operates in the electronic design automation sector, which is critical for the development of integrated circuits, positioning the company well in a growing technology market.
  • The company has a solid market capitalization of approximately $81.42 billion, reflecting its stability and established presence in the industry.

Synopsys
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Synopsys, Inc. for these reasons:

  • Despite the positive ratings, Wells Fargo & Company has cut their target price from $570.00 to $540.00, indicating some analysts may have concerns about the stock's near-term performance.
  • The stock has a relatively high PE ratio of 36.27, which may suggest that it is overvalued compared to its earnings, potentially making it a riskier investment.
  • With a PEG ratio of 3.22, the stock may not be growing fast enough to justify its current valuation, which could deter value-focused investors.
  • The trading volume has fluctuated, with recent trading volumes lower than average, which may indicate reduced investor interest or liquidity issues.
  • Company insiders own only 0.66% of the stock, which may suggest a lack of confidence from those closest to the company regarding its future performance.

SNPS Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Synopsys is $641.82, with a high forecast of $690.00 and a low forecast of $540.00.

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last year. There is currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SNPS shares.

According to analysts, Synopsys's stock has a predicted upside of 23.29% based on their 12-month stock forecasts.

Synopsys has been rated by research analysts at Loop Capital, Needham & Company LLC, Piper Sandler, Redburn Atlantic, Robert W. Baird, Rosenblatt Securities, and Wells Fargo & Company in the past 90 days.

Analysts like Synopsys more than other "computer and technology" companies. The consensus rating score for Synopsys is 2.91 while the average consensus rating score for "computer and technology" companies is 2.68. Learn more on how SNPS compares to other companies.


This page (NASDAQ:SNPS) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners